S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
Elon Musk's mysterious ways on display in Tesla tweet trial
Cassava Sciences Stock Undervalued with Its $124 Price Target?
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Why Extreme Networks is a Recession-Proof Technology Play
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
Elon Musk's mysterious ways on display in Tesla tweet trial
Cassava Sciences Stock Undervalued with Its $124 Price Target?
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Why Extreme Networks is a Recession-Proof Technology Play
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
Elon Musk's mysterious ways on display in Tesla tweet trial
Cassava Sciences Stock Undervalued with Its $124 Price Target?
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Why Extreme Networks is a Recession-Proof Technology Play
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
Elon Musk's mysterious ways on display in Tesla tweet trial
Cassava Sciences Stock Undervalued with Its $124 Price Target?
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Why Extreme Networks is a Recession-Proof Technology Play
NASDAQ:MASI

Masimo - MASI Stock Forecast, Price & News

$171.39
+1.38 (+0.81%)
(As of 01/27/2023 08:55 PM ET)
Add
Compare
Today's Range
$169.45
$171.96
50-Day Range
$138.49
$172.76
52-Week Range
$108.89
$237.85
Volume
241,700 shs
Average Volume
437,100 shs
Market Capitalization
$9.01 billion
P/E Ratio
56.75
Dividend Yield
N/A
Price Target
$188.00

Masimo MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.88 Rating Score
Upside/​Downside
9.7% Upside
$188.00 Price Target
Short Interest
Healthy
2.99% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.86
Upright™ Environmental Score
News Sentiment
0.38mentions of Masimo in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$5.99 M Bought Last Quarter
Proj. Earnings Growth
-1.80%
From $4.44 to $4.36 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.13 out of 5 stars

Medical Sector

463rd out of 1,049 stocks

Electromedical Equipment Industry

13th out of 24 stocks


MASI stock logo

About Masimo (NASDAQ:MASI) Stock

Masimo Corp. is a medical technology company, which develops, manufactures and markets noninvasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

Receive MASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

MASI Stock News Headlines

Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
Should You Hold Masimo Corporation (MASI)?
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Masimo Announces Limited Market Release of Sepsis Index
H2O: the FT investigation’s big finale
The Wall Street fight that has echoes of the cold war
See More Headlines
Receive MASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

MASI Company Calendar

Last Earnings
11/08/2022
Today
1/30/2023
Next Earnings (Estimated)
2/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:MASI
CUSIP
57479510
Employees
6,200
Year Founded
1989

Price Target and Rating

Average Stock Price Forecast
$188.00
High Stock Price Forecast
$295.00
Low Stock Price Forecast
$135.00
Forecasted Upside/Downside
+9.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.88
Research Coverage
8 Analysts

Profitability

Net Income
$229.65 million
Pretax Margin
12.28%

Debt

Sales & Book Value

Annual Sales
$1.24 billion
Cash Flow
$4.80 per share
Book Value
$28.00 per share

Miscellaneous

Free Float
47,466,000
Market Cap
$9.01 billion
Optionable
Optionable
Beta
0.86

Social Links


Key Executives

  • Joe E. KianiJoe E. Kiani
    Chairman & Chief Executive Officer
  • Bilal MuhsinBilal Muhsin
    Chief Operating Officer
  • Micah YoungMicah Young
    Chief Financial Officer & Executive Vice President
  • Yongsam Lee
    Chief Information Officer & Executive VP
  • Anand SampathAnand Sampath
    Executive VP-Operations & Clinical Research













MASI Stock - Frequently Asked Questions

Should I buy or sell Masimo stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MASI shares.
View MASI analyst ratings
or view top-rated stocks.

What is Masimo's stock price forecast for 2023?

8 brokers have issued 12-month price objectives for Masimo's stock. Their MASI share price forecasts range from $135.00 to $295.00. On average, they anticipate the company's stock price to reach $188.00 in the next twelve months. This suggests a possible upside of 9.7% from the stock's current price.
View analysts price targets for MASI
or view top-rated stocks among Wall Street analysts.

How have MASI shares performed in 2023?

Masimo's stock was trading at $147.95 at the start of the year. Since then, MASI stock has increased by 15.8% and is now trading at $171.39.
View the best growth stocks for 2023 here
.

When is Masimo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our MASI earnings forecast
.

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) issued its earnings results on Tuesday, November, 8th. The medical equipment provider reported $1.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.92 by $0.08. The medical equipment provider had revenue of $549.30 million for the quarter, compared to analysts' expectations of $533.96 million. Masimo had a trailing twelve-month return on equity of 18.04% and a net margin of 9.78%.

What guidance has Masimo issued on next quarter's earnings?

Masimo issued an update on its FY 2023 earnings guidance on Wednesday, December, 14th. The company provided earnings per share guidance of $4.25-$4.45 for the period, compared to the consensus earnings per share estimate of $4.43. The company issued revenue guidance of $2.33 billion-$2.40 billion, compared to the consensus revenue estimate of $2.36 billion.

What is Joe E. Kiani's approval rating as Masimo's CEO?

136 employees have rated Masimo Chief Executive Officer Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among the company's employees.

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO).

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Who are Masimo's major shareholders?

Masimo's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Baillie Gifford & Co. (0.18%), New York State Teachers Retirement System (0.12%), Allspring Global Investments Holdings LLC (0.09%), Assenagon Asset Management S.A. (0.05%), Yousif Capital Management LLC (0.05%) and Comerica Bank (0.04%). Insiders that own company stock include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Tao Levy, Thomas Samuel Mcclenahan and Yongsam Lee.
View institutional ownership trends
.

How do I buy shares of Masimo?

Shares of MASI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $171.39.

How much money does Masimo make?

Masimo (NASDAQ:MASI) has a market capitalization of $9.01 billion and generates $1.24 billion in revenue each year. The medical equipment provider earns $229.65 million in net income (profit) each year or $3.02 on an earnings per share basis.

How many employees does Masimo have?

The company employs 6,200 workers across the globe.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The official website for the company is www.masimo.com. The medical equipment provider can be reached via phone at (949) 297-7000, via email at ekammerman@masimo.com, or via fax at 949-297-7001.

This page (NASDAQ:MASI) was last updated on 1/30/2023 by MarketBeat.com Staff